Pembrolizumab

Secondary sclerosing cholangitis: case report

    This is a preview of subscription content, log in to check access.

    Reference

    1. Matsumoto S, et al. Pembrolizumab-induced secondary sclerosing cholangitis in a non-small cell lung cancer patient. Respirology Case Reports 8: No. 5, 10 Apr 2020. Available from: URL: http://doi.org/10.1002/rcr2.560

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Pembrolizumab. Reactions Weekly 1810, 173 (2020). https://doi.org/10.1007/s40278-020-80193-x

    Download citation